Background: HPV vaccines were introduced globally as one of the most effective strategies to prevent cervical cancer. HPV vaccines were rolled out in Kenya in 2019 targeting girls aged 10 - 14 years, but the uptake has not been satisfactory. ThePurpose of the Study: The aim of the study was to assess the level of HPV uptake among girls aged 10 - 14 years in Rongai and Nakuru West Sub-Counties in Nakuru County. Method: This was a cross-sectional study where data on HPV uptake was retrieved from all the public health facilities located in Rongai and Nakuru West Sub-Counties, Nakuru County, entered into Microsoft Excel then transferred to SPSS version 26 for analysis of HPV vaccine uptake since the year 2019 to June 2022. Data Analysis: Descriptive statistics were used where tables and graphs were generated to represent the percentages and trends of HPV vaccine uptake. Results: The average percentage of HPV uptake in Nakuru West Sub-County since the rollout of vaccination was 17% while that of Rongai Sub-County was 15%. In 2019, HPV 1 uptake was generally low for both Sub-Counties, the results show no HPV 2 vaccines were administered during that year. In 2020, Nakuru West reported an increase in HPV 1 uptake, while Rongai reported a drop in HPV 1 uptake. Both Sub-Counties reported an increase in HPV 2 in 2020 as compared to the previous year. The highest HPV 1 & 2 uptakes were reported in 2021 in both Sub-Counties. The uptake of both HPV 1 & 2 kept increasing subsequently. Conclusion: The overall uptake of HPV vaccines for Doses 1 and 2, in both Rongai and Nakuru West Sub-Counties, is low. However, there has been a consistent increase in uptake of the two doses in the two Sub-Counties since 2019. Therefore, raising public awareness of the importance of HPV vaccination could improve uptake.
References
[1]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[2]
International Agency for Research on Cancer, WHO (2020) Africa Cancer Fact Sheets. Globocan, 598, 1-2. https://gco.iarc.fr/today/data/factsheets/populations/903-africa-fact-sheets.pdf
[3]
Gultekin, M., Ramirez, P.T., Broutet, N. and Hutubessy, R. (2020) World Health Organization Call for Action to Eliminate Cervical Cancer Globally. International Journal of Gynecological Cancer, 30, 426-427. https://doi.org/10.1136/ijgc-2020-001285
[4]
Nabirye, J., Okwi, L.A., Nuwematsiko, R., Kiwanuka, G., Muneza, F., Kamya, C. and Babirye, J.N. (2020) Health System Factors Influencing Uptake of Human Papilloma Virus (HPV) Vaccine among Adolescent Girls 9-15 Years in Mbale District, Uganda. BMC Public Health, 20, Article No. 171. https://doi.org/10.1186/s12889-020-8302-z
[5]
Karanja-Chege, C.M. (2022) HPV Vaccination in Kenya: The Challenges Faced and Strategies to Increase Uptake. Frontiers in Public Health, 10, Article 802947. https://doi.org/10.3389/fpubh.2022.802947
[6]
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M.S., et al. (2021) HPV Vaccination Introduction Worldwide and WHO and UNICEF Estimates of National HPV Immunization Coverage 2010-2019. Preventive Medicine, 144, Article ID: 106399. https://doi.org/10.1016/j.ypmed.2020.106399
[7]
Aruho, C., Mugambe, S., Baluku, J.B. and Taremwa, I.M. (2022) Human Papillomavirus Vaccination Uptake and Its Predictors among Female Adolescents in Gulu Municipality, Northern Uganda. Adolescent Health, Medicine and Therapeutics, 13, 77-91. https://doi.org/10.2147/AHMT.S383872
[8]
Oluwole, E.O., Idowu, O.M., Adejimi, A.A., Balogun, M.R. and Osanyin, G.E. (2019) Knowledge, Attitude and Uptake of Human Papillomavirus Vaccination among Female Undergraduates in Lagos State, Nigeria. Journal of Family Medicine and Primary Care, 8, 3627-3633. https://doi.org/10.4103/jfmpc.jfmpc_520_19
[9]
McNutt, L.-A., Desemone, C., DeNicola, E., El Chebib, H., Nadeau, J.A., Bednarczyk, R.A., et al. (2016) Affluence as a Predictor of Vaccine Refusal and Underimmunization in California Private Kindergartens. Vaccine, 34, 1733-1738. https://doi.org/10.1016/j.vaccine.2015.11.063
[10]
Meites, E., Kempe, A. and Markowitz, L.E. (2016) Use of a 2-Dose Schedule for Human Papillomavirus Vaccination—Updated Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR), 65, 1405-1408. https://doi.org/10.15585/mmwr.mm6549a5
[11]
Brotherton, J.M., Budd, A., Rompotis, C., Bartlett, N., Malloy, M.J., Andersen, R.L., et al. (2019) Is One Dose of Human Papillomavirus Vaccine as Effective as Three?: A National Cohort Analysis. Papillomavirus Research, 8, Article ID: 100177. https://doi.org/10.1016/j.pvr.2019.100177
[12]
Walker, B., Anderson, A., Stoecker, C., Shao, Y., LaVeist, T.A. and Callison, K. (2022) COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid. Vaccine, 40, 837-840. https://doi.org/10.1016/j.vaccine.2021.12.022
[13]
Chao, C.R., Xu, L., Cannizzaro, N., Bronstein, D., Choi, Y., Riewerts, R., et al. (2022) Trends in HPV Vaccine Administration and HPV Vaccine Coverage in Children by Race/Ethnicity and Socioeconomic Status during the COVID-19 Pandemic in an Integrated Health Care System in California. Vaccine, 40, 6575-6580. https://doi.org/10.1016/j.vaccine.2022.09.073